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Oral inflammation, such as periodontitis, can lead to endothelial dysfunction, accelerated atherosclerosis, and vascular dysfunction.
The relationship between vascular dysfunction and other common forms of oral infections such as denture-related stomatitis (DRS)
is unknown. Similar risk factors predispose to both conditions including smoking, diabetes, age, and obesity. Accordingly, we aimed
to investigate endothelial function andmajor vascular disease risk factors in 44 consecutive patients with dentures with clinical and
microbiological features of DRS (𝑛 = 20) and without DRS (𝑛 = 24). While there was a tendency for higher occurrence of diabetes
and smoking, groups did not differ significantly in respect to major vascular disease risk factors. Groups did not differ in main
ambulatory blood pressure, total cholesterol, or even CRP. Importantly, flow mediated dilatation (FMD) was significantly lower in
DRS than in non-DRS subjects, while nitroglycerin induced vasorelaxation (NMD) or intima-media thickness (IMT) was similar.
Interestingly, while triglyceride levels were normal in both groups, they were higher inDRS subjects, although they did not correlate
with either FMDorNMD.Conclusions. Denture related stomatitis is associatedwith endothelial dysfunction in elderly patients with
dentures. This is in part related to the fact that diabetes and smoking increase risk of both DRS and cardiovascular disease.
1. Introduction
Oral inflammation is an important element in the patho-
genesis of vascular disease. In particular, large body of
evidence has accumulated recently that chronic periodon-
titis is a potential novel risk factor for atherosclerosis and
endothelial dysfunction [1–5]. Indeed, intensive treatment
of chronic periodontitis alleviates endothelial dysfunction
in a long-term follow-up, with clinical benefit lasting up
to 6 months after intensive treatment [6]. The mechanisms
of this association are not clearly defined but are most
likely dependent on systemic inflammatory response, involv-
ing increased levels of IL-6, CRP, TNF-alpha, and other
cytokines, which accompany periodontitis [6, 7]. Moreover,
cellular immunity is also activated in periodontitis, including
monocyte subpopulation shift as well as T cell activation with
overproduction of interferon gamma and IL-17 [8].
While numerous studies have focused on the links
between periodontitis and endothelial dysfunction, little
is known about the links between other forms of oral
infection and inflammation in the context of cardiovascular
risk. In particular, denture-related stomatitis (DRS) is an
inflammatory process of the oral mucosa in contact with a
denture and is one of the most common diseases in elderly
patients, affecting up to 70% of patients in the course of life
[9, 10]. It is most common in complete prosthesis wearers,
Hindawi Publishing Corporation
BioMed Research International
Volume 2014, Article ID 474016, 9 pages
http://dx.doi.org/10.1155/2014/474016
2 BioMed Research International
edentulous subjects [9–11].Thepotential links are particularly
worth addressing, as major risk factors for DRS include
smoking, diabetes, age, and obesity, which coincide with risk
of atherosclerosis and vascular disease [9, 12, 13]. Thus it
is even more surprising that this problem of concomitant
incidence of both conditions has not been studied up to
date. Interestingly, the relationship of DRS to dyslipidemia is
not known and female sex appears to predispose to higher
occurrence [9]. Clinical symptoms of DRS include erythema
and swelling of palatal mucosa, sometimes combined with
subjective symptoms, such as dysgeusia or burning sensation.
The aetiology of the DRS is multifactorial [9]. Long-term
and continuous use of dentures and poor denture and oral
hygiene habits promote the development of a biofilm, called
denture plaque, on the surface of the prosthesis [9, 12].
Candida albicans is fungal component of the physiological
microflora of the human oral cavity [14, 15]; however, factors
mentioned above may promote its excessive growth and,
consequently, the development of infection and DRS.
While in periodontitis systemic activation of the immune
system is very important in mediating increased cardiovas-
cular risk, the extent of systemic response to DRS is poorly
characterized. Systemic inflammation may affect vascular
dysfunction in number of ways, which include activation of
monocytes and T cells with overproduction of cytokines such
as interferon 𝛾, TNF-alpha, interleukin 6, or 17 [16], sub-
sequently leading to atherosclerosis and hypertension [16–
18] and increased cardiovascular risk. Interestingly, increased
cardiovascular risk has been shown also for caries [19–21],
as well as endodontic infection [22–26]. These diseases are
all caused by bacterial infections, but, other microorganisms
are also able to infect oral tissues. Relationship between
fungal infection in oral cavity and systemic inflammatory
response in context of vascular risk has not yet been studied.
Therefore, the aim of this study was to determine whether
the presence of DRS coincides with the clinical measures of
vascular dysfunction, such as impaired endothelial function
or elevated blood pressure.
2. Methods
2.1. Patients. Using 44 consecutive patients with dental pros-
theses for at least 6 months were included in this study.
Their oral mucosa was examined by the dentist to clinically
identify inflammation and DRS. The clinical signs of oral
mucosa inflammation in DRS include erythema and swelling
of palatal mucosa, sometimes combined with subjective
symptoms, such as dysgeusia or burning sensation. These
observations were confirmed by routine microbiological
laboratory diagnostic tests for Candida species presence.
Based on clinical andmicrobiological investigations, patients
were divided into DRS (𝑛 = 20) group and non-DRS
(𝑛 = 24) group. Diagnosis was confirmed by an independent
observer. Control, non-DRS patients had clinically healthy
oral mucosa and negative oral Candida swabs. Clinically
healthy oral mucosa was a pale pink, smooth mucosal
membrane without redness or swelling and with no pain or
discomfort reported by patient. Exclusion criteria included
acute inflammatory disorders other than DRS, neoplastic
disease relapses or chemotherapy courses less than 5 years
before the enrolment, and using antibiotics in less than 4
weeks or anti-inflammatory drugs (steroids and nonsteroidal,
excluding aspirin in doses less than 80mg) in less than
2 months before the enrolment. Patients with history of
myocardial infarction, acute coronary incident or vascular
inflammation in 5weeks or less before the enrolment, chronic
haematological disorders, and immunodeficiency or major
medication changes during less than 5 weeks before or
during study were also excluded. The study was approved by
local ethics committee of Jagiellonian University. Informed
consent was obtained from all patients and all work was
conducted in accordance with the Declaration of Helsinki
(1964).
2.2. Microbiological Investigations. Swabs were taken from
the hard palate (between the second and third palatal fold).
Samples were collected after an overnight fast and after
at least 6 hours of continous denture usage, without the
use of adhesives or rinsing the mouth with disinfectants.
The material was collected in accordance with the general
principles of microbial material collection.
2.3. Clinical Data. Patients’ blood pressure (systolic, dias-
tolic) was monitored for 24 hours using ambulatory blood
pressure monitoring system (ABPM; SpaceLabs 90217, Ultra-
lite device). Systolic diastolic and mean arterial pressures
were recorded every 20 minutes for 24 hours. Day and night
averages were calculated. One patient in control group did
not agree to wear the ABPM monitor. Major risk factors
for both atherosclerosis and DRS were recorded based on
patient medical records and detailed patient history. Clinical
risk factors were defined as follows: hyperlipidemia (total
plasma cholesterol level> 5mmol/L and/or triglycerides level
> 1,7mmol/L), diabetes (fasting glucose level ≥ 7mmol/L
or HbA1c > 6.5% or current treatment with insulin or
oral hypoglycemic agents), hypertension (blood pressure ≥
140/90mmHg or current treatment with antihypertensive
agents), and smoking (current or within last 6 months) based
on [27]. Blood samples were obtained from antecubital vein
and lipoprotein profile was assessed by routine diagnostic
measurements of triglycerides, total cholesterol, low-(LDL),
and high-(HDL) density lipoprotein cholesterol fractions. C-
reactive protein (CRP) concentration was also assessed as in
routine diagnostics.
2.4. Endothelial Function Measurement. Flow-mediated dil-
atation (FMD) method was used to determine the vascular
endothelial function and NMD (nitroglycerine-mediated
dilatation) for measuring endothelial-independent vasodi-
latation. Measurements were conducted using Toshiba Xario
Diagnostic Ultrasound System after 1, 2, and 4-5 minutes
after manometer cuff deflation or sublingual administration
of nitroglycerine and presented as percentage of the diameter
of the artery before intervention. Method validation in our
laboratory has been described elsewhere [28].Observerswere
blinded regarding oral status of the patients.
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Table 1: Patient clinical characteristics.
DRS group
𝑛 = 20
Control group
𝑛 = 24
Gender (M : F) 2 : 18 𝑃 > 0,05 6 : 18
Age [mean (SD)] 63,9 (6,6) 𝑃 > 0,05 65,9 (10,3)
BMI [median (𝑄1; 𝑄2)] 28,5 (24,9; 33,6) 𝑃 > 0,05 27,8 (24,3; 29,3)
Smoking (%) 6 (30%) 𝑃 > 0,05 3 (12,5%)
Diabetes mellitus (%) 6 (30%) 𝑃 > 0,05 2 (8,3%)
Hypertension (%) 17 (85%) 𝑃 > 0,05 19 (79,2%)
Hyperlipidemia (%) 13 (65%) 𝑃 > 0,05 12 (50%)
Medications (%)
ACE inhibitor 7 (35%) 𝑃 > 0,05 12 (50%)
Acetylsalicylic acid 3 (15%) 𝑃 > 0,05 4 (17%)
𝛽-blocker 7 (35%) 𝑃 > 0,05 10 (42%)
Ca antagonist 3 (15%) 𝑃 > 0,05 8 (34%)
Diuretic 7 (35%) 𝑃 > 0,05 6 (25%)
Statin 6 (30%) 𝑃 > 0,05 5 (21%)
Insulin 2 (10%) 𝑃 > 0,05 2 (8,3%)
Oral antidiabetic agents 2 (10%) 𝑃 > 0,05 2 (8,3%)
ACE: angiotensin converting enzyme, BMI: body mass index, DM: diabetes mellitus, SD: standard deviation.
2.5. Subclinical Atherosclerosis Assessment. The measure-
ments of intima-media thickness were performed in 12
different points (2 cm below common carotid arteries bulbs,
ca. every 1 cm, omitting visible coronary plaques), on right
and left common carotid artery, measuring the distance
between the border between artery lumen and carotid artery
intima and second bright line-m (border between media and
adventitia) as described previously [28].
2.6. Statistical Analysis. Analysis was performed using Stat-
soft Statistica software. Compliance of the distribution of
variables with normal distribution was tested by Shapiro-
Wilk test. Most of the variables did not have normal distri-
butions, and therefore the results are presented as medians
and 25th (Q1), 75th (Q3) percentiles. For those variables
nonparametric statistical tests were used, Mann-Whitney 𝑈
test for continuous variables or, for dichotomous variables,𝜒2
for the expected frequencies > 5 or 𝜒2 with Yates’ correction
for the expected frequencies < 5 with confirmation of Fisher’s
exact test and Spearman correlation. For variables with
normal distribution Student’s 𝑡-test was applied and data are
presented as mean with standard deviation (SD). Method of
presentation of results is given for each variable in the text.
Values of 𝑃 < 0, 05 were considered statistically significant.
3. Results
3.1. Clinical Risk Factors in Studied Groups. Both groups
were balanced in terms of age, sex, body mass index (BMI)
value, and antihypertensive treatment. There were more
smokers and patients with diabetes mellitus (DM) in DRS
group than in control group, although these differences were
not statistically significant. Higher prevalence of DM and
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Figure 1: Ambulatory blood pressure parameters in control and
DRS patients. Blood pressure parameters were assessed by 24 h
measurement with ambulatory blood pressure monitoring system.
Results are presented as mean (SD); 𝑛 control group = 23, 𝑛 DRS
group = 20.
smoking in DRS group is consistent with epidemiologic data
and is understandable, as both are recognized as a risk factor
for developing DRS [13]. The proportion of males in both
study groups was lower than expected for general population,
which is consistent with the epidemiology of DRS, which
is more common in females [9]. Patients characteristics are
summarized in Table 1.
3.2. Blood Pressure in Denture Related Stomatitis. Ambula-
tory blood pressure monitoring has shown no significant
differences in both mean systolic and mean diastolic blood
pressure in DRS and control non-DRS group (Figure 1).
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Figure 2: Vascular dysfunction in control and DRS. Vascular
endothelium-dependent flow-mediated dilatation (FMD) and en-
dothelium-independent nitroglycerin-mediated dilatation (NMD)
parameters were assessed by ultrasonography. Results presented as
median (Q1; Q2); ∗𝑃 < 0, 005; 𝑛 control group = 24, 𝑛 DRS group =
20.
Moreover, subsequent analysis of blood pressures during
activity and rest periods did not show significant differences
either (data not shown).
3.3. Vascular Function. Flow-mediated dilatation measure-
ments showed a significantly reduced median percentage of
arterial dilation in response to flow in the DRS group in
comparison with control patients (Figure 2). At the same
time there was no difference between groups in endothelium-
independent vasodilatation, NMD (Figure 2). There was no
difference in baseline vessel diameter between control and
DRS group (3, 7 ± 0, 8mm versus 3, 8 ± 0, 7mm; 𝑃 = 0, 4).
3.4. Subclinical and Clinical Atherosclerosis. Intima-media
thickness evaluation showed no significant differences in
either maximal or mean IMT in studied groups. It is impor-
tant to point out that neither of the groups showed very
high values of mean IMT (Figure 3). Moreover, presence of
the atherosclerotic lesions of common carotid artery was
equally distributed between groups; it was detected in 37.5%
of patients from control group and in 35% of DRS group,
𝑃 = 0, 86.
3.5. Plasma Lipid Profile and CRP. As the elevated blood
triglycerides, LDL and total cholesterol levels and low HDL
cholesterol levels are recognized as cardiovascular risk fac-
tors; we compared their concentrations in blood samples
collected from patients with oral fungal infection and with
healthy oral mucosa. We found that plasma levels of total,
LDL, and HDL cholesterol were similar in both groups;
however, triglycerides levels were significantly elevated in
DRS group (Figure 4(a)). Surprisingly, CRP levels were sim-
ilar between studied groups, indicating lack of significant
component of systemic inflammation in DRS (Figure 4(b)).
As the level of triglycerides was different between groups and
this parameter may impact vascular function, we checked if
there is a correlation between FMDorNMDand triglycerides
levels. We found that these parameters were not correlated in
case of FMD (𝑅 Spearman = −0,13, 𝑃 = 0, 42) and NMD (𝑅
Spearman = −0,025, 𝑃 = 0, 87) (Figure 5).
3.6. Subgroup Analysis in Female Subpopulation Only. As
there was a much lower proportion of males in our study
population, we performed an additional subgroup analysis
in female population. It revealed that all studied vascular
phenomena were observed to the same extent as in total
studied population, including the difference in endothelium
derived vasorelaxations (FMD (mean ± SD): 5, 95 ± 3, 80%
in female DRS patients and 9, 72 ± 3, 31% in control subjects;
𝑃 = 0, 0032) and TG levels (median [Q1; Q2]: 1,61 [1,46; 1,99]
in DRS versus 1,09 [0,86; 1,34] in non-DRS; 𝑃 = 0, 01).
4. Discussion
The oral health impact on the general health is evident.
Oral infections and inflammation have been implicated in
many disease entities, such as rheumatoid arthritis [29],
obesity [30], negative pregnancy outcomes [31], DM [32],
and even in epilepsy [33]. In particular, the role of oral
inflammation and infection in the modulation of the risk
of cardiovascular disorders has been well defined [1–5].
These studies have, however, focused mainly on periodontal
inflammation and gingival bleeding. In the present study
we investigated the relationships between denture-related
stomatitis, a common oral inflammatory condition in elderly
patients with endothelial dysfunction, blood pressure, and
lipid profile. We observed that denture-related stomatitis
which occurs in ca. 60% of patients wearing dentures, is
associated with significant reduction of endothelial function,
measured as nitric oxide bioavailability in a clinical flow-
mediated dilatation study. Importantly, control, nitroglycerin
induced endothelium-independent vasodilatation was not
changed. As it is known that the severity of endothelial dys-
function correlates with the development of coronary artery
disease and predicts future cardiovascular events [34], our
results implicate that the presence of DRS may be associated
with negative cardiovascular outcomes. Thus, such patients
should be particularly carefully monitored in relation to their
cardiovascular risk. Considering that DRS is one of the most
common oral disorders in the elderly, occurring in 40–70%
of subjects wearing dentures [9, 10], our finding may have
important implications for clinical care of denture wearing
patients. It is important to note, however, that majority of
patients studied here were females which is consistent with
the epidemiology of DRS, that is, more common in females
[9]. We have also performed an additional analysis in female
subpopulation only, which confirmed all major observations
of this study.
While numerous previous studies have shown increased
cardiovascular risk in subjects with oral inflammatory condi-
tions such as periodontitis [1–5], endodontic infections [22–
26], and even caries [19–21], this is the first study focusing
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Figure 3: IMT measurements in DRS and control group. (a) Mean common carotid artery intima-media thickness. Results are presented as
mean (SD); (b) maximal common carotid artery intima-media thickness. Results presented as median (Q1; Q2). (a) and (b): 𝑛 control group
= 24, 𝑛 DRS group = 20.
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Figure 4: Plasma lipid profile andC-reactive protein levels in control andDRS patients. (a) Comparison of lipid profiles. Results are presented
asmedian (Q1;Q2); ∗𝑃 < 0, 05; (b) comparison of plasma CRP concentrations. Results are presented asmedian (Q1;Q2). (a) and (b): 𝑛 control
group = 24, 𝑛 DRS group = 18.
on vascular dysfunction in elderly population of patients
wearing dentures. This is important, while previous studies
focused on bacteria-mediated, resulting from disturbances
of physiological oral microflora diseases, we have primarily
studied fungal infection, as DRS is most commonly associ-
ated with Candida infection.
Previous studies focused on a positive association
between periodontitis and vascular endothelial dysfunction.
Amar et al. and Blum et al. observed that subjects with
advanced periodontal disease exhibit worse endothelial func-
tion when compared to the healthy controls [35, 36]. Blum
et al. [36], along with others [6, 37], reported also an
improvement of endothelial function as a long-term outcome
of periodontal treatment. Tonetti et al. [6] in a landmark
study has shown in a proper randomized controlled trial
that such improvement provides clinical benefit for up to 6
months after intensive treatment.
The mechanisms of increased cardiovascular risk in oral
inflammatory conditions are multifactorial and range from
chronic systemic inflammation (periodontitis) to the effects
of risk factors such as diabetes, hyperlipidemia, smoking,
and age which predispose to both cardiovascular diseases
and oral disorders, such as periodontitis [1–5], caries [19–21],
endodontic infections [22–26], or DRS [9, 12, 13]. This coin-
cidence of risk factors is visible in the population of patients
we have studied. Although the difference in occurrence of
smoking or diabetes did not reach statistical significance,
we can clearly see increased occurrence of these factors
6 BioMed Research International
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Figure 5: Spearman correlation between parameters of vascular function parameters and triglycerides levels. (a) Spearman correlation
between FMD and triglycerides levels: 𝑅 Spearman = −0,13, 𝑃 = 0,42; (b) Spearman correlation between NMD and triglycerides levels:
𝑅 Spearman = −0, 025, 𝑃 = 0, 87; (a) and (b): 𝑛 = 42.
in DRS. This can in part explain the increased degree of
endothelial dysfunction in DRS subjects. Measurement of
baseline FMDprior to developingDRS in a long-term follow-
up study would unquestionably strengthen the conclusions
of this study. Alternatively, a future interventional study
in which the effect of treatment of DRS on endothelial
function could also help to address this issue in amore cause-
effect manner. Importantly, as the population we studied
was relatively young for denture carriers, no significant
increase in intima-media thickness was detected yet. This is
in agreement with numerous cardiovascular studies which
show that endothelial dysfunction precedes the development
of severe atherosclerosis [38].
The role of systemic inflammation, very well defined in
periodontitis, is not known inDRS.Themechanisms through
which DRS could affect endothelial dysfunction are unclear.
In periodontitis, bacteria lead to the activation of the local
immune response, leading to systemic inflammation. Simi-
larly, immune stimulation of T cells and monocytes has been
reported in response to fungal C. albicans antigens [39, 40].
However, in our study we did not find significantly increased
levels of total CRP, which could suggest that local Candida-
evoked oral mucosal inflammation is not causing significant
activation of systemic inflammatory response.TheCRP levels
among edentulous were assessed by Ajwani et al. at Helsinki
Aging Study involving over 600 patients older than 75 years
old [41]. They identified mucosal lesions in the edentulous as
an important factor associatedwith elevatedCRP level among
elderly individuals and observed that it was significantlymore
common among the edentulous with complete dentures.
Importantly, patients having clinical signs of oral candidosis
or denture stomatitis also showed elevated levels of CRP,
and authors suggested that it may be the explanation of the
elevated CRP levels seen in the edentulous. In our study, we
have also seen a trend toward higher CRP values in DRS
patients, but it did not reach statistical significance, probably
because of small numbers of patients involved and the fact
that we have not measured high sensitivity hsCRP which
would better characterize cardiovascular risk [42]. In the
light of our results, assessing other markers of the systemic
inflammation becomes a very interesting aspect for further
studies. Taking into account our results, at present our data
do not support the hypothesis that systemic inflammation
is involved. Rather, the effect of concomitant risk factors on
DRS and vascular function is most likely.
DeOliveira et al. and Rodriguez-Archilla et al. have found
that oral Candida infection may impact peripheral blood
mononuclear cells state, measured by amount of cytokines
produced in vitro in response to Candida antigens [39, 40].
Direct impact of Candida cells on the vascular system is
unlikely, since systemic fungal infections are characterized, in
contrast to the DRS, by extremely serious symptoms; more-
over, fungal DNA has not been detected in atherosclerotic
lesions [43].
However our results may point us to the potential role of
vascular risk factors such as diabetes, smoking, and hyper-
triglyceridemia in mediating vascular dysfunction. Although
no relationship was found between triglyceride levels and
endothelial dysfunction in a simple correlation analysis,
whenmultivariate linear regressionwas introduced including
diabetes, smoking, and/or triglyceride levels, the difference
in endothelial function was no longer significant (data not
shown). One has to however bear in mind that statistical
power of such analysis in the studied group was relatively
modest.
While the finding that classical risk factors may be
main mediators of endothelial dysfunction may not sound
exceptionally interesting, it is very important to show that
this is the case in DRS subjects, and therefore this group of
patients should be carefully studied in larger epidemiological
trials. This is particularly important in the light of ageing
population.
Despite the lack of differences in the levels of total, HDL,
and LDL cholesterol in the blood of healthy subjects and
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DRS, we observed significantly higher levels of triglycerides
in patients with DRS. Our surprising finding that DRS is
associated with selective increase in triglyceride levels is
quite intriguing and could be related to the fact that denture
wearing can change dietary habits. It could also suggest that
increased triglyceride levels could be a risk factor of DRS,
although our study was not powered to answer this question.
There are no studies looking at lipid parameters inDRS, while
conflicting data are available regarding periodontitis. Sandi et
al. and Penumarthy et al. observed higher concentrations of
total cholesterol and LDL cholesterol in the blood of patients
with periodontal disease than in healthy group, but the
differences in the levels of triglycerides and HDL cholesterol
were shown only by Penumarthy et al., despite the smaller
sample sizes [44, 45]. Simultaneously, Elter et al. did not
demonstrate changes in the total cholesterol and HDL levels
after treatment of periodontitis [37]. Altogether, these results
can point to a potential relationship between oral infection
and blood lipid profile, but conclusive evidence is still needed.
We did not observe the tendency towards elevated blood
pressure in patients with DRS as compared to healthy
subjects. This shows potential important difference in oral
inflammatory conditions as periodontitis is potentially asso-
ciated with elevated blood pressure, which was frequently
observed [46]. The relationship between the use of dental
prostheses and the prevalence of cardiovascular diseases,
including elevated blood pressure, was discussed by Buhlin
et al. [2]. They found positive association between dentures
and all cardiovascular diseases but not for elevated blood
pressure, myocardial infarction, or stroke. However, the
group defined as “dentures” was very heterogeneous. The
authors gathered together edentulous and partially eden-
tulous denture wearers and edentulous without dentures.
This creates potential bias of the presence of periodontitis
in partially edentulous patients. Importantly, in our study
virtually all subjects were completely edentulous (41 out of
44).
5. Conclusions
In conclusion, our study shows that patients with denture-
related stomatitis are characterized by more pronounced
systemic endothelial dysfunction than denture subjects with-
out stomatitis. This difference in vascular function is likely
linked with increased cardiovascular risk in DRS and indi-
cates that such patients should be carefully monitored for
cardiovascular disease. While our study identifies certain
very interesting and potentially very important cardiovas-
cular aspects of denture-related stomatitis, a larger study is
warranted to finally confirm these observations. This may
be very important for clinical practice considering ageing
population.
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